Clinical Study
Investigation on Carbohydrate Counting Method in Type 1 Diabetic Patients
Table 2
The progress of the metabolic markers of the patients in the carbohydrate counting group.
| | Carbohydrate counting group () | values | | Pre-treatment baseline values | Values at 6 months |
| TA (mmHg) | | | = 0.065 | Systolic | 109.77 ± 5.24 | 122.04 ± 2.60 | ( > 0.05) | Diastolic | 74.09 ± 1.63 | 79.54 ± 0.72 | = 0.005 | | | | () | Fasting blood glucose (mg/dL) | 149.63 ± 17.65 | 160.40 ± 19.00 | = 0.630 ( > 0.05) | Post-prandial blood glucose (mg/dL) | 174.59 ± 15.46 | 169.27 ± 8.05 | = 0.710 ( > 0.05) | HbA1c (%) | 8.14 ± 0.48 | 8.00 ± 0.38 | = 0.699 ( > 0.05) | Fructosamine (mg/dL) | 417.77 ± 22.56 | 404.90 ± 23.59 | = 0.525 ( > 0.05) | Uri acid (mg/dL) | 3.43 ± 0.26 | 3.94 ± 0.30 | = 0.003 () | Total cholesterol (mg/dL) | 174.50 ± 8.24 | 170.77 ± 6.41 | = 0.534 ( > 0.05) | Triglyceride (mg/dL) | 79.04 ± 6.83 | 75.90 ± 5.87 | = 0.587 ( > 0.05) | HDL cholesterol (mg/dL) | 71.18 ± 4.19 | 67.40 ± 3.44 | = 0.112 ( > 0.05) | LDL cholesterol (mg/dL) | 84.49 ± 7.01 | 92.86 ± 6.01 | = 0.120 ( > 0.05) | Total cholesterol/HDL cholesterol ratio | 2.52 ± 0.18 | 2.71 ± 0.18 | = 0.174 ( > 0.05) |
|
|